Immune-mediated colitis after resumption of immune checkpoint inhibitor therapy.
Year: 2019
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Hamzah Abu-Sbeih, Faisal Ali, Abdul Rafeh Naqash, Dwight Hall Owen, Sandip H. Patel, Gregory Alan Otterson, Kari Lynn Kendra, Biagio Ricciuti, Rita Chiari, Andrea De Giglio, Joseph Sleiman, Pauline Funchain, Wills Beatriz, Jiajia Zhang, Jarushka Naidoo, Jessica Philpott, Jianjun Gao, Sumit Kumar Subudhi, Yinghong Wang
Institutions: The University of Texas MD Anderson Cancer Center, Amita Health, Saint Joseph Hospital, Vidant Medical Center, East Carolina University, The Ohio State University, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Dana-Farber Cancer Institute, University of Perugia, Cleveland Clinic, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2947774775